Home 2018-04-25T17:07:17+00:00

Product Finder

Product Finder

GMP Quality

With over 20 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space.

CellGenix was the first company to obtain a GMP manufacturing authorization for therapeutic cell processing in Europe. Being an ATMP manufacturer ourselves allowed us to gain in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements you face during product development and the regulatory approval process. We can help simplify your raw material qualificatition and validation efforts by offering expert technical and regulatory support. 

 

 

We are able to guarentee a consistent high product quality as all relevant GMP guidelines are followed for each step from initial development to final Quality Control (QC) release after manufacturing.

Our GMP grade raw materials offer a maximum of quality and safety due to state-of-the-art production, stringent quality control and comprehensive documentation.

Read more

Safe │ GMP Compliant │ Reliable 

 

 

 

GMP Quality

With over 20 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space.

Our GMP grade raw materials offer a maximum of quality and safety due to state-of-the-art production, stringent quality control and comprehensive documentation.

Read more 

News

  • Mar 2018

    Technote - Consistency Studies

    To make sure your manufacturing process is not influenced by using different batches of GMP cytokines, we have performed batch-to-batch consistency studies for our key CellGenix® GMP cytokines.

    Read more

  • Jan 2018

    Press Release CellGenix - January

    CEVEC and CellGenix cooperation leads to expansion of CellGenix cytokine portfolio with CAP®GO Technology-derived TGF-β1. After CellGenix® rh HGF, CellGenix® rh TGF-β1 is the second product originating from this cooperation.

    Read more

  • Jan 2018

    New Preclinical Cytokine

    We proudly announce the launch of CAP® cell line derived recombinant human Transforming Growth Factor-beta 1. This product contains neither animal- nor human-derived materials ensuring maximum safety for optimal use in preclinical cell and gene therapy applications.

    Read more

Events

May 2018
02/05 - 05/05

ISCT 2018

Montréal | Canada
 
29/05 - 30/05

Bioprocessing of Advanced Cellular Therapies | BACT 2018

Frankfurt/Main | Germany

Where are you located?

Note: You have to select a country.